1. Robotic-Assisted Surgery in Gynecological Oncology
- Author
-
Stephen H. Bush and Sachin M. Apte
- Subjects
medicine.medical_specialty ,Genital Neoplasms, Female ,medicine.medical_treatment ,MEDLINE ,law.invention ,Gynecologic Surgical Procedures ,Randomized controlled trial ,Robotic Surgical Procedures ,law ,Laparotomy ,medicine ,Humans ,Laparoscopy ,medicine.diagnostic_test ,business.industry ,Endometrial cancer ,General surgery ,technology, industry, and agriculture ,Hematology ,General Medicine ,medicine.disease ,Robotic assisted surgery ,Surgery ,body regions ,Oncology ,Female ,Complication ,business - Abstract
Background Robotic-assisted surgery is a technological advancement, and its use is rapidly expanding into the field of gynecological oncology. However, a paucity of evidence exists to prove its superiority over standard laparoscopy. Its cost is also high and it lacks haptic feedback. Methods A systematic review of the relevant literature was undertaken to understand the use of robotic-assisted surgery in gynecological oncology. Results Robotic-assisted surgery is being used for select cases of endometrial cancer and has resulted in the increased utilization of minimally invasive surgery for such patients. Use of robotic-assisted surgery among patients who are obese has led to decreased complication rates. Robotic-assisted surgery appears to be more expensive than traditional laparoscopy; however, there are potential cost savings to robotic-assisted surgery, including shorter hospital stays and fewer complications, compared with laparotomy. Conclusions The gynecological oncology community is rapidly accepting the use of robotic-assisted surgery. Although randomized controlled trials are lacking, the technology appears to be safe and effective, and it has equivalent oncological outcomes in this patient population.
- Published
- 2015